Assignee
COCRYSTAL PHARMA INC
US·14 granted patents·5 pending applications·86 citations·filing 2013–2022
Top patents by PatentIndex Score
19 records- 0196US9173893B2Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infectionsCOCRYSTAL PHARMA INC·Filed 2013·Granted Nov 3, 2015·52 cites·16 claims
- 0291US9181227B2Potent and selective inhibitors of hepatitis C virusCOCRYSTAL PHARMA INC·Filed 2014·Granted Nov 10, 2015·8 cites·5 claims
- 0389US9809616B2Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancerCOCRYSTAL PHARMA INC·Filed 2013·Granted Nov 7, 2017·15 cites·11 claims
- 0487US11014941B2Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2018·Granted May 25, 2021·4 cites·20 claims
- 0583US10947210B2Inhibitors of Hepatitis C virus polymeraseCOCRYSTAL PHARMA INC·Filed 2019·Granted Mar 16, 2021·2 cites·8 claims
- 0683US10464914B2Inhibitors of hepatitis C virus polymeraseCOCRYSTAL PHARMA INC·Filed 2016·Granted Nov 5, 2019·5 cites·21 claims
- 0760US2024398757A1Inhibitors for coronavirusesCOCRYSTAL PHARMA INC·Filed 2022·Application pending·0 cites
- 0856US2023159453A1Inhibitors of norovirus and coronavirus replicationCOCRYSTAL PHARMA INC·Filed 2021·Application pending·0 cites
- 0954US12233066B2Combinations of inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2019·Granted Feb 25, 2025·0 cites·20 claims
- 1052US12357631B2Pyrrolo[2,3-B]pyridin derivatives as inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2019·Granted Jul 15, 2025·0 cites·19 claims
- 1151US11752166B2Combination therapy for treatment of HCVCOCRYSTAL PHARMA INC·Filed 2019·Granted Sep 12, 2023·0 cites·19 claims
- 1251US2023151034A1Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replicationCOCRYSTAL PHARMA INC·Filed 2021·Application pending·0 cites
- 1350US12156876B2Formulations of influenza therapeuticsCOCRYSTAL PHARMA INC·Filed 2019·Granted Dec 3, 2024·0 cites·19 claims
- 1447US12565488B2Inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2019·Granted Mar 3, 2026·0 cites·24 claims
- 1546US12037333B2Pyridopyrazine and pyridotriazine inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2019·Granted Jul 16, 2024·0 cites·22 claims
- 1641US9926295B2Potent and selective inhibitors of hepatitis C virusCOCRYSTAL PHARMA INC·Filed 2015·Granted Mar 27, 2018·0 cites·13 claims
- 1739US2017037078A12' -disubstituted nucleoside analogs for treatment of the flaviviridae family of viruses and cancerCOCRYSTAL PHARMA INC·Filed 2015·Application pending·0 cites
- 1837US2017334941A12',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancerCOCRYSTAL PHARMA INC·Filed 2015·Application pending·0 cites
- 1934US10011629B2Nucleoside analogs for treatment of the flaviviridae family of viruses and cancerCOCRYSTAL PHARMA INC·Filed 2016·Granted Jul 3, 2018·0 cites·17 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →